- Home
- CKPT vs ONCY Comparison
CKPT vs ONCY Comparison
Compare CKPT & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKPT
- ONCY
- Stock Information
- Founded
- CKPT 2014
- ONCY 1998
- Country
- CKPT United States
- ONCY Canada
- Employees
- CKPT N/A
- ONCY N/A
- Industry
- CKPT Biotechnology: Pharmaceutical Preparations
- ONCY Pharmaceuticals and Biotechnology
- Sector
- CKPT Health Care
- ONCY Health Care
- Exchange
- CKPT Nasdaq
- ONCY Nasdaq
- Market Cap
- CKPT N/A
- ONCY 103.8M
- IPO Year
- CKPT 2017
- ONCY 1999
- Fundamental
- Price
- CKPT $3.77
- ONCY $1.19
- Analyst Decision
- CKPT Strong Buy
- ONCY Strong Buy
- Analyst Count
- CKPT 2
- ONCY 2
- Target Price
- CKPT $12.00
- ONCY $4.00
- AVG Volume (30 Days)
- CKPT 946.5K
- ONCY 903.7K
- Earning Date
- CKPT 11-11-2024
- ONCY 11-05-2024
- Dividend Yield
- CKPT N/A
- ONCY N/A
- EPS Growth
- CKPT N/A
- ONCY N/A
- EPS
- CKPT N/A
- ONCY N/A
- Revenue
- CKPT $78,000.00
- ONCY N/A
- Revenue This Year
- CKPT N/A
- ONCY N/A
- Revenue Next Year
- CKPT $151,162.55
- ONCY N/A
- P/E Ratio
- CKPT N/A
- ONCY N/A
- Revenue Growth
- CKPT N/A
- ONCY N/A
- 52 Week Low
- CKPT $1.36
- ONCY $0.84
- 52 Week High
- CKPT $3.95
- ONCY $1.80
- Technical
- Relative Strength Index (RSI)
- CKPT 84.67
- ONCY 52.51
- Support Level
- CKPT $2.37
- ONCY $1.17
- Resistance Level
- CKPT $2.54
- ONCY $1.28
- Average True Range (ATR)
- CKPT 0.27
- ONCY 0.09
- MACD
- CKPT 0.10
- ONCY -0.01
- Stochastic Oscillator
- CKPT 88.60
- ONCY 28.00
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatment. The other projects in the company's pipeline include, Bracelet-1 for treatment of Breast Cancer, Goblet cohort-1, Goblet cohort-5 for treatment of Gastro-Intestinal Cancer among others.